DAY ONE BIOPHARMACEUTICALS INC (DAWN)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jeremy Bender Chief Executive Officer and President | 2024 | $680,000 | $0 | $2,700,280 | $2,664,697 | $501,800 | $13,800 | $6,560,577 |
| 2023 | $647,000 | $0 | $1,779,160 | $4,086,399 | $388,200 | $13,200 | $6,913,959 | |
| 2022 | $610,000 | $0 | $812,820 | $3,361,436 | $290,000 | $12,200 | $5,086,456 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Charles N. York II Chief Operating Officer and Chief Financial Officer | 2024 | $541,000 | $0 | $1,530,640 | $1,511,240 | $299,400 | $13,800 | $3,896,080 |
| 2023 | $515,000 | $0 | $842,760 | $1,943,333 | $231,800 | $13,200 | $3,546,093 | |
| 2022 | $495,000 | $0 | $313,720 | $1,278,531 | $220,000 | $12,200 | $2,319,451 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Samuel Blackman Co-Founder and Head of Research and Development | 2024 | $527,000 | $0 | $1,400,680 | $1,381,724 | $291,700 | $13,800 | $3,614,904 |
| 2023 | $500,000 | $0 | $538,430 | $1,206,462 | $227,300 | $13,200 | $2,485,392 | |
| 2022 | $470,000 | $0 | $270,940 | $1,143,057 | $181,000 | $12,200 | $2,077,197 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Adam Dubow General Counsel, Chief Compliance Officer and Secretary | 2024 | $455,000 | $0 | $851,960 | $840,954 | $223,900 | $13,800 | $2,385,614 |
| 2023 | $425,000 | $0 | $655,840 | $1,509,573 | $170,000 | $13,200 | $2,773,253 |